0.9 C
New York
Tuesday, December 18, 2018
- Advertisement -

Lucy Munizoffline

  • 3.1K

    Posts

  • 1

    Comments

  • 535

    Views

Indivior to launch cheaper opioid addiction drug; maintains forecast

(Reuters) - British drugmaker Indivior Plc said on Tuesday it would launch a cheaper version of its blockbuster opioid addiction treatment drug, while maintaining...

read more

China first to approve AstraZeneca, FibroGen anaemia drug

FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble LONDON (Reuters) - China...

read more

J&J announces $5 billion share buyback after shares extend losses

(Reuters) - Johnson & Johnson said on Monday it plans to buy back up to $5 billion of its stock, after a Reuters report...

read more

Virion Biotherapeutics Appoints Edwin Moses as Chairman of the Board and Guido Dietrich as Head of Manufacturing

LONDON--(BUSINESS WIRE)--Virion Biotherapeutics today announced the appointment of Edwin Moses, PhD, former CEO of Ablynx, as Chairman of its Board of Directors. In addition,...

read more

BrainStorm gets FDA okay for stem cell trial in MS patients

TEL AVIV (Reuters) - BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its...

read more
Please wait ...